# ğŸ§¬ Generative Models for Drug Discovery
ğŸ”¬ Project Focus: Accelerating drug discovery using generative models and deep **reinforcement learning**

ğŸ“˜ Project Overview
This project explores the use of generative deep learning for designing novel molecular structures with potential therapeutic properties. Leveraging the vast ZINC database of chemical compounds, the pipeline generates, validates, and optimizes new drug candidates.

The goal is to automate the early stages of drug discovery by generating molecules that are not only chemically valid but also optimized for specific biological or physicochemical properties.

ğŸ› ï¸ Key Technologies and Methods
Variational Autoencoders (VAEs) for learning continuous representations of molecules.

Graph Neural Networks (GNNs) for capturing molecular structure and predicting properties.

Reinforcement Learning (RL) for molecular optimization, rewarding desirable properties.

SMILES and molecular graph representations.

RDKit for molecular validation and manipulation.

ğŸ§ª Dataset
ZINC Database

A curated dataset of over 230 million commercially available molecules.

Used for training generative models and virtual screening.

ZINC Database Link

ğŸ§  Inspiration from Literature
Automatic Chemical Design Using a Data-Driven Continuous Representation of Molecules
Introduced the use of VAEs for molecular generation.
ACS Central Science

Molecular Graph Convolutions: Moving Beyond Fingerprints
Demonstrated the strength of GNNs in molecular feature learning.
Journal of Computer-Aided Molecular Design

Optimization of Molecules via Deep Reinforcement Learning
Applied RL for property-guided molecular optimization.
Scientific Reports

ğŸ Outcomes
Built a generative pipeline capable of producing novel, chemically valid molecules.

Used deep reinforcement learning to optimize drug candidates for target properties.

Evaluated molecules computationally for validity, drug-likeness, and synthetic accessibility.
